Literature DB >> 35191077

Clinical, pathologic, and molecular analyses of superficial low-grade fibromyxoid sarcoma in two young patients: A rare and deceptive mimic of benignancy.

Mitul B Modi1, Susan Pei2, Matthew L Hedberg2, Andrew S Fischer2, Jessenia Guerrero3, Chrystalle Katte Carreon3,4, Kumarasen Cooper1, John T Seykora2.   

Abstract

Low-grade fibromyxoid sarcoma (LGFMS) is a histopathologically deceptive soft tissue neoplasm with bland cytology, which is typically encountered in deep soft tissue of adults. We report two cases of superficial LGFMS in young patients (16 and 21 years old, respectively), which were difficult to diagnose on histopathologic and clinical findings alone. LGFMS commonly mimics benign neoplasms such as cellular neurothekeoma, fibromatosis, neurofibroma, and perineurioma. Malignancies included in the differential diagnosis are soft tissue neoplasms such as dermatofibrosarcoma protuberans and myxofibrosarcoma. A high degree of reported variation in pattern and cellularity among LGFMS further complicates the diagnosis. Careful examination and appropriate immunohistochemistry panels including MUC4 are essential for narrowing the differential diagnosis. Molecular studies for possible FUS translocation can confirm the diagnosis of LGFMS. Sufficient sampling and workup of these lesions are critical, especially in younger patients. Young age and superficial presentation can easily sway dermatopathologists/dermatologists toward an incorrect diagnosis of benignancy.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FUS translocation; MUC4; pediatric; soft tissue neoplasm; superficial low-grade fibromyxoid sarcoma

Mesh:

Year:  2022        PMID: 35191077      PMCID: PMC9232983          DOI: 10.1111/cup.14215

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.458


  23 in total

1.  Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.

Authors:  I Panagopoulos; C Lassen; M Isaksson; F Mitelman; N Mandahl; P Aman
Journal:  Oncogene       Date:  1997-09       Impact factor: 9.867

2.  Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).

Authors:  Wei-Lien Wang; Empar Mayordomo; Wenyong Zhang; Vivian S Hernandez; Daniel Tuvin; Lisa Garcia; Dina C Lev; Alexander Jf Lazar; Dolores López-Terrada
Journal:  Mod Pathol       Date:  2009-06-26       Impact factor: 7.842

3.  Low-grade fibromyxoid sarcoma of superior turbinate in a pediatric patient.

Authors:  Yasin Kursad Varsak; Hamdi Arbag; Huri Sultan Yesildemir; Hasan Esen
Journal:  J Craniofac Surg       Date:  2015-05       Impact factor: 1.046

4.  EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.

Authors:  Cristina R Antonescu; Lei Zhang; Ning-En Chang; Bruce R Pawel; William Travis; Nora Katabi; Morris Edelman; Andrew E Rosenberg; G Petur Nielsen; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

5.  MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.

Authors:  Leona A Doyle; Emely Möller; Paola Dal Cin; Christopher D M Fletcher; Fredrik Mertens; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

6.  Pediatric low-grade fibromyxoid sarcoma mimicking ossifying fibromyxoid tumor: adding to the diagnostic spectrum of soft tissue tumors with a bony shell.

Authors:  Khin Thway; Julia Chisholm; Andrew Hayes; John Swansbury; Cyril Fisher
Journal:  Hum Pathol       Date:  2014-11-26       Impact factor: 3.466

7.  Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.

Authors:  Fredrik Mertens; Christopher D M Fletcher; Cristina R Antonescu; Jean-Michel Coindre; Maurizio Colecchia; Henryk A Domanski; Erinn Downs-Kelly; Cyril Fisher; John R Goldblum; Louis Guillou; Robin Reid; Juan Rosai; Raf Sciot; Nils Mandahl; Ioannis Panagopoulos
Journal:  Lab Invest       Date:  2005-03       Impact factor: 5.662

8.  EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.

Authors:  Patrick P L Lau; Philip C W Lui; Gene T C Lau; Derek T W Yau; Elaine T Y Cheung; John K C Chan
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

9.  Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity.

Authors:  J R Goodlad; T Mentzel; C D Fletcher
Journal:  Histopathology       Date:  1995-03       Impact factor: 5.087

10.  Low-grade fibromyxoid sarcoma with nuclear pleomorphism arising in the subcutis of a child.

Authors:  Michael P Sedrak; Douglas C Parker; Jerad M Gardner
Journal:  J Cutan Pathol       Date:  2013-11-05       Impact factor: 1.587

View more
  1 in total

1.  Low-grade fibromyxoid sarcoma in the middle ear as a rare location: a case report.

Authors:  Yingyuan Guo; Yanru Hao; Guofang Guan
Journal:  Transl Pediatr       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.